No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
OSTX OS Therapies
- 1.600
- -0.080-4.76%
Close Mar 7 16:00 ET
- 1.600
- 0.0000.00%
Post 20:01 ET
35.09MMarket Cap-4.57P/E (TTM)
1.700High1.510Low244.13KVolume1.650Open1.680Pre Close396.98KTurnover1.62%Turnover RatioLossP/E (Static)21.93MShares7.00052wk High-50.00P/B24.05MFloat Cap1.41052wk Low--Dividend TTM15.03MShs Float7.000Historical High--Div YieldTTM11.31%Amplitude1.410Historical Low1.626Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Join OS Therapies' Exclusive Live Investor Webinar and Q&A Session on February 27
Express News | Os Therapies Inc - in Discussions to Form Joint Ventures With ADC Companies
OS Therapies Launches Subsidiary to Advance Tunable Antibody Drug Conjugates, Plans Stock Dividends for Shareholders
OS Therapies Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for Its Tunable ADC & Drug Conjugates Platforms
Express News | Os Therapies Forms Subsidiary Os Drug Conjugates and Initiates Review of Strategic Options for Its Tunable ADC & Drug Conjugates Platforms